Zika antiviral chemotherapy: identification of drugs and promising starting points for drug discovery from an FDA-approved library

Background The recent epidemics of Zika virus (ZIKV) implicated it as the cause of serious and potentially lethal congenital conditions such microcephaly and other central nervous system defects, as well as the development of the Guillain-Barré syndrome in otherwise healthy patients. Recent findings...

Descripción completa

Detalles Bibliográficos
Autores principales: Pascoalino, Bruno S., Courtemanche, Gilles, Cordeiro, Marli T., Gil, Laura H. V. G., Freitas-Junior, Lucio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112578/
https://www.ncbi.nlm.nih.gov/pubmed/27909576
http://dx.doi.org/10.12688/f1000research.9648.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112578/
https://www.ncbi.nlm.nih.gov/pubmed/27909576
http://dx.doi.org/10.12688/f1000research.9648.1

Ejemplares similares